E/C/F/TDF
GS-US-236-0128
Phase 3 small_molecule completed
Quick answer
E/C/F/TDF for Acquired Immunodeficiency Syndrome is a Phase 3 program (small_molecule) at Gilead Sciences Ireland UC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Gilead Sciences Ireland UC
- Indication
- Acquired Immunodeficiency Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed